Analyst firms · Wolfe Research · INSP
Wolfe Research INSP price target and rating history
Inspire Medical Systems Inc. (INSP) · Health Care
Wolfe Research rates Inspire Medical Systems Inc. (INSP) Peer Perform with a $180 price target, as of its latest action on Feb 13, 2026. It has published 3 rating actions on INSP since April 2022, including 1 upgrade and 1 downgrade. Across 12 firms with a INSP price target in the last 12 months, the median target is $72. Wolfe Research's $180 is 150% above that.
- Current rating
- Peer Perform
- Price target
- $180
- Median target, all firms
- $72
- Actions on INSP
- 3
Wolfe Research price target on INSP
Every Wolfe Research rating on INSP
- Feb 13, 2026
- Nov 25, 2025
- Apr 6, 2022
How other firms rate INSP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Underweight | $65 | Oct 7, 2026 |
| Oppenheimer | Outperform | $85 | Aug 4, 2026 |
| UBS | Sell | $39 | Jul 28, 2026 |
| Evercore ISI | In-line | $40 | Jun 23, 2026 |
| BofA Securities | Underperform | $39 | May 22, 2026 |
| Piper Sandler | Neutral | $55 | May 5, 2026 |
| Wolfe Research | Peer Perform | $180 | Feb 13, 2026 |
| Robert W. Baird | Neutral | $74 | Feb 12, 2026 |
| Wells Fargo | Equal Weight | $70 | Feb 12, 2026 |
| RBC Capital Markets | Sector Perform | $90 | Jan 27, 2026 |
| Truist Securities | Hold | $96 | Jan 22, 2026 |
| Morgan Stanley | Equal-Weight | $130 | Dec 2, 2025 |
| Stifel | Buy | Nov 24, 2025 |
Questions about Wolfe Research and INSP
- What is Wolfe Research's price target for INSP?
- Wolfe Research's latest stated price target for Inspire Medical Systems Inc. (INSP) is $180, from its action on Nov 25, 2025.
- What is Wolfe Research's rating on INSP?
- Wolfe Research rates INSP Peer Perform, a neutral rating, as of Feb 13, 2026.
- When did Wolfe Research last change its view on INSP?
- On Feb 13, 2026, Wolfe Research downgrades to Peer Perform from Outperform.
- How does Wolfe Research's INSP target compare with other analysts?
- Across 12 firms with a INSP price target in the last 12 months, the median target is $72. Wolfe Research's $180 is 150% above that.
More INSP rating histories
- Oppenheimer3
- UBS3
- BofA Securities5
- Piper Sandler5
- Wells Fargo4
- Truist Securities4
- KeyBanc Capital Markets3
- Leerink Partners4
All Wolfe Research ratingsINSP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.